News|Articles|April 2, 2004

Pharmaceutical Technology

  • Pharmaceutical Technology-04-02-2004
  • Volume 28
  • Issue 4

Controlled-Release Dosage Forms for Diltiazem Hydrochloride

The authors investigate whether an extrusion-spheronization proces can be used to develop a matrix-based, controlled-release formulation for a highly water-soluble drug.
External Link - article-91088.pdf

Articles in this issue

almost 22 years ago

Spotlight on Business Risk

almost 22 years ago

Vibration Technology for Active Dry-Powder Inhalers

almost 22 years ago

In the Spotlight April 2004

almost 22 years ago

FDA Attacks Counterfeits

almost 22 years ago

Synthetic Excipients Challenge All-Natural Organics

almost 22 years ago

April 2004

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!

Related Content